About This Calculator

The Oxaliplatin Dose Calculator is designed to assist healthcare professionals in determining the appropriate dose of oxaliplatin for patients undergoing chemotherapy. It streamlines the calculation process by using standard clinical formulas: the Mosteller formula for Body Surface Area (BSA) and the Cockcroft-Gault equation for estimating Creatinine Clearance (CrCl). This tool is intended for educational and informational purposes and does not replace clinical judgment.

Outputs Explained

After entering the required patient data, the calculator provides the following key outputs:

• Body Surface Area (BSA): Calculated in square meters (m²), this value is fundamental for dosing most chemotherapy agents, including oxaliplatin.
• Creatinine Clearance (CrCl): An estimate of renal function in mL/min. This is crucial for identifying patients who may require dose adjustments due to impaired kidney function.
• Total Oxaliplatin Dose: The final recommended dose in milligrams (mg) for the current cycle, based on the BSA and the selected dose per m².
• Clinical Alerts: The tool generates warnings for situations that require special attention, such as severe renal impairment (CrCl < 30 mL/min) or high cumulative doses that increase the risk of neurotoxicity.

How to Use the Calculator

To calculate the oxaliplatin dose, follow these steps:

1. Enter Patient Demographics: Input the patient's age, biological sex, weight, and height. Ensure the correct units (e.g., kg/lbs, cm/in) are selected.
2. Input Laboratory Values: Provide the patient's most recent serum creatinine level.
3. Select Dosing Parameters: Choose the relevant chemotherapy regimen (e.g., FOLFOX, CAPOX) or select "Custom" to enter a specific dose in mg/m².
4. Enter Optional Data: For cumulative dose tracking, input the total dose of oxaliplatin from all previous cycles. You can also apply an institutional BSA cap if required.
5. Calculate and Review: Click the "Calculate Dose" button to see the results. Carefully review the calculated dose and any accompanying alerts.

Oxaliplatin Dosing Overview

Oxaliplatin is a platinum-based antineoplastic agent used in the treatment of colorectal cancer. Dosing is individualized based on the patient's BSA. Standard doses vary by regimen:

• FOLFOX / FOLFIRINOX: Typically 85 mg/m² administered as an intravenous infusion every 2 weeks.
• CAPOX (or XELOX): Typically 130 mg/m² administered as an intravenous infusion every 3 weeks.

Dose adjustments are critical for managing toxicities. The dose-limiting toxicity is primarily peripheral sensory neuropathy, which is related to the cumulative dose. Renal function is also important, and a dose reduction is recommended for patients with severe renal impairment (CrCl < 30 mL/min).

Switching Regimens

Switching a patient from one chemotherapy regimen to another, or from one platinum agent to another (e.g., from cisplatin to oxaliplatin), is a complex clinical decision made by the treating oncologist. It depends on factors like disease progression, prior toxicities, and overall patient health. This calculator does not provide guidance on switching therapies.

Missed or Delayed Dose

Oxaliplatin is administered in a supervised healthcare setting according to a specific cycle schedule. If a planned administration is delayed or missed due to factors like myelosuppression or patient illness, the treating healthcare team will determine the appropriate course of action. This may involve rescheduling the infusion or adjusting the dose for the next cycle based on clinical assessment.

Safety Alerts

Cumulative Dose and Neurotoxicity

The most significant long-term side effect of oxaliplatin is peripheral sensory neuropathy. The risk and severity increase with the cumulative dose. The calculator provides a warning when the total cumulative dose approaches or exceeds 850 mg/m², a threshold at which severe neuropathy becomes more common. Continuous monitoring for symptoms like paresthesia, dysesthesia, or pain is essential.

Renal Impairment

Oxaliplatin is cleared by the kidneys. In patients with severe renal impairment (Creatinine Clearance < 30 mL/min), drug exposure is increased, raising the risk of toxicity. For these patients, a dose reduction is typically recommended. The calculator flags this condition to prompt clinical review.

Frequently Asked Questions

What formula is used to calculate BSA?

The calculator uses the Mosteller formula, which is a widely accepted method for estimating Body Surface Area: BSA (m²) = √([Height(cm) × Weight(kg)] / 3600).

How does the calculator determine creatinine clearance?

It uses the Cockcroft-Gault equation. This formula estimates CrCl based on age, weight, serum creatinine, and sex.

Does the calculator adjust for obesity when calculating CrCl?

Yes. If a patient's actual body weight is more than 120% of their ideal body weight (IBW), the calculator automatically uses the adjusted body weight (AdjBW) in the Cockcroft-Gault formula for a more accurate CrCl estimate.

What is the purpose of the BSA cap?

Some institutions cap the BSA value used for chemotherapy calculations (e.g., at 2.0 m² or 2.2 m²) to avoid potential toxicity from very high doses in patients with extreme obesity. This feature allows clinicians to apply their local institutional policy.

Why is biological sex a required input?

Biological sex is a variable in the Cockcroft-Gault equation. The formula includes a correction factor that results in a lower estimated CrCl for females compared to males with the same age, weight, and serum creatinine.

What is the recommended dose modification for neurotoxicity?

For persistent Grade 2 neurotoxicity, a dose reduction to 65 mg/m² (from 85 mg/m²) is often considered. For Grade 3-4 neurotoxicity, discontinuation of oxaliplatin is typically recommended.

Can this calculator be used for carboplatin dosing?

No. This tool is exclusively for oxaliplatin. Carboplatin dosing requires the Calvert formula, which uses the Glomerular Filtration Rate (GFR) or CrCl and a target Area Under the Curve (AUC).

Is this tool a substitute for professional medical advice?

Absolutely not. This calculator is an educational support tool. All treatment decisions must be made by a qualified healthcare professional based on a full clinical evaluation of the patient.

References

• Oxaliplatin Prescribing Information. U.S. Food and Drug Administration (FDA). View at FDA.gov
• Mosteller RD. Simplified calculation of body-surface area. N Engl J Med. 1987;317(17):1098. View at NEJM.org
• Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41. View on PubMed
• Gressett SM, et al. Comparison of the Cockcroft-Gault and Modification of Diet in Renal Disease formulas for calculating GFR in cancer patients. J Oncol Pharm Pract. 2009;15(4):227-34. View on PubMed